These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 11685039

  • 1. Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model.
    Guerrero B, Arocha-Piñango CL, Pinto MA, Müller CA, Gil San Juan AG, Amorim S, Perales J.
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):521-9. PubMed ID: 11685039
    [Abstract] [Full Text] [Related]

  • 2. Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosis.
    Rapold HJ, Wu ZM, Stassen T, Van de Werf F, Collen D.
    Blood; 1990 Oct 15; 76(8):1558-63. PubMed ID: 2119830
    [Abstract] [Full Text] [Related]

  • 3. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR, Wu Z, Pauwels P, Lijnen HR, Collen D.
    J Am Coll Cardiol; 1992 May 15; 19(6):1350-9. PubMed ID: 1342779
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model.
    Lu HR, Lijnen HR, Stassen JM, Collen D.
    Blood; 1991 Jul 01; 78(1):125-31. PubMed ID: 1906351
    [Abstract] [Full Text] [Related]

  • 6. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D, Stassen JM, Verstraete M.
    J Clin Invest; 1983 Feb 01; 71(2):368-76. PubMed ID: 6681615
    [Abstract] [Full Text] [Related]

  • 7. Time course of thrombolysis induced by intravenous bolus or infusion of tissue plasminogen activator in a rabbit jugular vein thrombosis model.
    Clozel JP, Tschopp T, Luedin E, Holvoet P.
    Circulation; 1989 Jan 01; 79(1):125-33. PubMed ID: 2491972
    [Abstract] [Full Text] [Related]

  • 8. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Nagashima M, Werner M, Wang M, Zhao L, Light DR, Pagila R, Morser J, Verhallen P.
    Thromb Res; 2000 May 15; 98(4):333-42. PubMed ID: 10822080
    [Abstract] [Full Text] [Related]

  • 9. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G, Pascucci C, Nenci GG, Mele A, Bürgi R, Heim J.
    Thromb Haemost; 1993 Aug 02; 70(2):294-300. PubMed ID: 8236138
    [Abstract] [Full Text] [Related]

  • 10. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D, Stassen JM, De Cock F.
    Thromb Haemost; 1987 Oct 28; 58(3):943-6. PubMed ID: 3124288
    [Abstract] [Full Text] [Related]

  • 11. A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity.
    Hirata Y, Umemura K, Takiguchi Y, Uematsu T, Nakashima M.
    Blood Coagul Fibrinolysis; 1993 Aug 28; 4(4):569-75. PubMed ID: 7692999
    [Abstract] [Full Text] [Related]

  • 12. Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis.
    Badylak SF, Voytik S, Klabunde RE, Henkin J, Leski M.
    Thromb Res; 1988 Nov 15; 52(4):295-312. PubMed ID: 3144052
    [Abstract] [Full Text] [Related]

  • 13. Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbits.
    Spriggs DJ, Stassen JM, Hashimoto Y, Collen D.
    Blood; 1989 Apr 15; 73(5):1207-12. PubMed ID: 2495034
    [Abstract] [Full Text] [Related]

  • 14. Thrombolytic effect after sequential double-bolus administration of tissue plasminogen activator and urokinase-fibrinogen conjugate into dogs with venous thrombosis.
    Maksimenko AV, Tischenko EG, Golubykh VL.
    Ann N Y Acad Sci; 1998 Dec 13; 864():409-17. PubMed ID: 9928118
    [No Abstract] [Full Text] [Related]

  • 15. Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor--and kringle one-domains.
    Emeis JJ, Verheijen JH.
    Arzneimittelforschung; 1992 Mar 13; 42(3):358-62. PubMed ID: 1497699
    [Abstract] [Full Text] [Related]

  • 16. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D, Lu HR, Lijnen HR, Nelles L, Stassen JM.
    Circulation; 1991 Sep 13; 84(3):1216-34. PubMed ID: 1909220
    [Abstract] [Full Text] [Related]

  • 17. Comparative studies of thrombolysis with single-chain and two-chain recombinant tissue-type plasminogen activators in canine coronary thrombosis.
    Yokoyama M, Ichikawa Y, Yatani A, Matsui K, Nakahara H, Kaneko M, Sakurama T, Ueshima S, Matsuo O.
    J Cardiovasc Pharmacol; 1996 Oct 13; 28(4):571-5. PubMed ID: 8891884
    [Abstract] [Full Text] [Related]

  • 18. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X, Berthiller J, Derex L, Trouillas P, Diallo L, Hanss M.
    J Neurol Sci; 2015 Feb 15; 349(1-2):77-83. PubMed ID: 25619569
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombin.
    Abercrombie DM, Buchinski B, Salvato KA, Vovis GF, Stump DC, Broeze RJ.
    Thromb Haemost; 1990 Nov 30; 64(3):426-32. PubMed ID: 2128973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.